These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18289651)

  • 1. HPV16 and increased risk of recurrence after treatment for CIN.
    Kafali H
    Gynecol Oncol; 2008 May; 109(2):309-10; author reply 310-1. PubMed ID: 18289651
    [No Abstract]   [Full Text] [Related]  

  • 2. HPV16 and increased risk of recurrence after treatment for CIN.
    Gök M; Coupé VM; Berkhof J; Verheijen RH; Helmerhorst TJ; Hogewoning CJ; Snijders PJ; Meijer CJ
    Gynecol Oncol; 2007 Feb; 104(2):273-5. PubMed ID: 17157365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
    Kudoh A; Sato S; Itamochi H; Komatsu H; Nonaka M; Sato S; Chikumi J; Shimada M; Oishi T; Kigawa J; Harada T
    Int J Clin Oncol; 2016 Jun; 21(3):580-7. PubMed ID: 26614089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent HPV-16 infection leads to recurrence of high-grade cervical intraepithelial neoplasia.
    Byun JM; Jeong DH; Kim YN; Jung EJ; Lee KB; Sung MS; Kim KT
    Medicine (Baltimore); 2018 Dec; 97(51):e13606. PubMed ID: 30572469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS.
    Banović M; Mahovlić V; Salopek KM; Banović V; Babić I; Orešković S; Babić D
    Pathol Oncol Res; 2015 Jul; 21(3):613-7. PubMed ID: 25432549
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of HPV DNA HR assay in females as a marker of recurrent disease following treatment of cervical intraepithelial neoplasia.
    Mikolajczyk K; Kedzia W; Zaba R; Silny W
    Ginekol Pol; 2011 Sep; 82(9):670-4. PubMed ID: 22379926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study.
    Kocken M; Helmerhorst TJ; Berkhof J; Louwers JA; Nobbenhuis MA; Bais AG; Hogewoning CJ; Zaal A; Verheijen RH; Snijders PJ; Meijer CJ
    Lancet Oncol; 2011 May; 12(5):441-50. PubMed ID: 21530398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV genotypes in CIN 2-3 lesions and cervical cancer: a population-based study.
    Sigurdsson K; Taddeo FJ; Benediktsdottir KR; Olafsdottir K; Sigvaldason H; Oddsson K; Rafnar T
    Int J Cancer; 2007 Dec; 121(12):2682-7. PubMed ID: 17724723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade cervical intraepithelial neoplasia, human papillomavirus and factors connected with recurrence following surgical treatment.
    Ramos MC; Pizarro De Lorenzo BH; Michelin MA; Murta EF
    Clin Exp Obstet Gynecol; 2008; 35(4):242-7. PubMed ID: 19205435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV, HPV and cervical pathology].
    Quéreux C; Bory JP
    Contracept Fertil Sex; 1997 Feb; 25(2):120-4. PubMed ID: 9116771
    [No Abstract]   [Full Text] [Related]  

  • 11. HPV testing in the follow-up after treatment of women with CIN.
    von Keyserling H; Kaufmann AM; Schneider A
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S5-7. PubMed ID: 17764728
    [No Abstract]   [Full Text] [Related]  

  • 12. Cervical cancer prevention - a paradigm shift?
    Denny L; De Sousa M; Kuhn L; Pollack A; Wright TC
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S12. PubMed ID: 16450428
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
    Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
    Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent infection with human papillomavirus following the successful treatment of high grade cervical intraepithelial neoplasia.
    Cruickshank ME; Sharp L; Chambers G; Smart L; Murray G
    BJOG; 2002 May; 109(5):579-81. PubMed ID: 12066952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women: A Systematic Review and Meta-analysis.
    Lichter K; Krause D; Xu J; Tsai SHL; Hage C; Weston E; Eke A; Levinson K
    Obstet Gynecol; 2020 May; 135(5):1070-1083. PubMed ID: 32282601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
    Nagai Y; Maehama T; Asato T; Kanazawa K
    Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure.
    Cecchini S; Carozzi F; Confortini M; Zappa M; Ciatto S
    Tumori; 2004; 90(2):225-8. PubMed ID: 15237586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical question: ask the expert.
    Tseng AG; Dornfest F
    J Low Genit Tract Dis; 2009 Apr; 13(2):118-9. PubMed ID: 19387134
    [No Abstract]   [Full Text] [Related]  

  • 19. [To analyse the histopathological results of patients with HPV16/18 positive and colposcopic suspicious lesions].
    Zhang JX; Zheng TP; Liu J; Wang QX; Zhan YX; Zhang ZY
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):467-472. PubMed ID: 28797154
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of high-grade cervical intraepithelial neoplasia (CIN 2/3) or cancer during follow-up of human papillomavirus (HPV) infection or CIN 1.
    Cestero RM
    Am J Obstet Gynecol; 2006 Nov; 195(5):1196-7. PubMed ID: 17074542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.